Fatty liver index as a predictor of fatal and non-fatal cardiovascular events in Russians: analysis of an epidemiological cohort

Read full text
Authors: С. Е. Евстифеева, Svetlana Anatolievna Shalnova, Vladimir Aleksandrovich Kutsenko, Капустина Анна Владимировна, Муромцева Галина Аркадьевна, Yu. А. Balanova, А. Э. Имаева, N. S. Karamnova, Marina B. Kotova, S.A. Maksimov, Olga A. Litinskaya, Maria Sergeevna Pokrovskaya
+10 more Филичкина Елена Михайловна, Anna G. Soplenkova, Гоманова Лилия Ильинична, Olga B. Shvabskaya, Yu. Yu. Samokhina, I. A. Viktorova, N. N. Prishchepa, А Н Редько, S. S. Yаkushin, Драпкина О. М.
Cited by: 0
References: 28

Abstract

Aim. To study the associations of a high fatty liver index (FLI ≥60) with the risk of death and nonfatal cardiovascular events in a Russian epidemiological cohort. Material and methods. The analysis included data from ESSE-RF2 epidemiological study. FLI was calculated using the Bedogni G et al. equation (2006). A high FLI ≥60 was considered a predictor of liver steatosis. A total of 5381 individuals aged 25-64 years from 4 Russian regions (the Republic of Karelia, Krasnodar Krai, Omsk and Ryazan Oblasts) were included, of which 1672 had FLI ≥60. Fatal endpoints included all-cause (ACD) and cardiovascular death (CVD), while nonfatal endpoints included myocardial infarction (MI), cerebrovascular accident (CVA), heart failure progression (hospitalization), and revascularization. The composite endpoint (CE) included cardiovascular death or a non-fatal endpoint. Statistical analysis was performed using the R language and environment (version 4.2). The significance level for all tested hypotheses was p

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Diabetes Cardiovascular Risks and Lipoproteins Healthcare Systems and Public Health

Publication details

Journal / source
CARDIOVASCULAR THERAPY AND PREVENTION
Volume
24
Issue
12
Pages
4589–4589
Publication date
8 February 2026
Language
EN